2009

In order to expand the range of pharmaceutical manufacturing services into APIs, a plant near Basel in Switzerland was acquired in 2009. This acquisition has broaden the scope of contract manufacturing services provided by The Group from secondary manufacture into primary manufacturing – Drug’on Pharma Switzerland.